Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Scheduled to Post Earnings on Thursday
Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) is scheduled to be posting its quarterly earnings results after the market closes on Thursday, August 3rd. Analysts expect Allscripts Healthcare Solutions to post earnings of $0.15 per share for the quarter.
Allscripts Healthcare Solutions (NASDAQ:MDRX) last issued its quarterly earnings data on Thursday, May 4th. The software maker reported $0.10 earnings per share for the quarter, topping the consensus estimate of $0.09 by $0.01. The business had revenue of $415 million during the quarter, compared to the consensus estimate of $415.20 million. Allscripts Healthcare Solutions had a negative net margin of 2.93% and a positive return on equity of 5.75%. The company’s revenue was up 20.1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.13 EPS. On average, analysts expect Allscripts Healthcare Solutions to post $0.62 EPS for the current fiscal year and $0.71 EPS for the next fiscal year.
Allscripts Healthcare Solutions, Inc. (NASDAQ MDRX) opened at 12.51 on Thursday. The firm’s market capitalization is $2.27 billion. The stock has a 50 day moving average of $12.43 and a 200-day moving average of $12.09. Allscripts Healthcare Solutions, Inc. has a one year low of $9.80 and a one year high of $15.17.
In related news, President Richard J. Poulton sold 25,000 shares of the stock in a transaction on Tuesday, May 16th. The stock was sold at an average price of $12.06, for a total value of $301,500.00. Following the completion of the transaction, the president now owns 412,488 shares in the company, valued at approximately $4,974,605.28. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 0.75% of the company’s stock.
Several brokerages recently issued reports on MDRX. Piper Jaffray Companies restated a “hold” rating and set a $14.00 price objective on shares of Allscripts Healthcare Solutions in a research note on Friday, July 21st. Bank of America Corporation began coverage on Allscripts Healthcare Solutions in a research note on Monday, May 15th. They issued a “neutral” rating and a $14.00 target price on the stock. BidaskClub upgraded Allscripts Healthcare Solutions from a “strong sell” rating to a “sell” rating in a research note on Tuesday, June 13th. Maxim Group reiterated a “buy” rating and issued a $16.00 target price on shares of Allscripts Healthcare Solutions in a research note on Friday, May 5th. Finally, Cantor Fitzgerald reiterated a “neutral” rating and issued a $13.00 target price on shares of Allscripts Healthcare Solutions in a research note on Monday, May 15th. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and ten have given a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus target price of $14.74.
Allscripts Healthcare Solutions Company Profile
Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.
Receive News & Ratings for Allscripts Healthcare Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions Inc. and related companies with MarketBeat.com's FREE daily email newsletter.